(195 days)
The Zefon Anesthesia Circuit with Bacterial Filter is intended for use in the administration of medical gases during anesthesia. The circuit connects the anesthesia gas machine to the patient by means of an oronasal face mask or by a connection to an artificial airway, such as an endotracheal tube. In the case of the Zefon circuit, a heat moisture exchange filter is included to minimize viral and bacterial contamination of the inspiratory and expiratory limbs of the circuit.
Not Found
I am sorry, but based on the provided document, I cannot describe the acceptance criteria and the study that proves the device meets those criteria. The document is a 510(k) clearance letter from the FDA for a device called "Zefon Anesthesia Circuit with Bacterial Filter." This letter confirms that the device is substantially equivalent to legally marketed predicate devices, allowing it to proceed to market.
However, the letter does not contain any details about:
- Acceptance criteria for performance evaluation.
- Specific studies (e.g., clinical trials, bench testing) conducted for the device.
- Sample sizes, data provenance, expert qualifications, adjudication methods, MRMC studies, standalone performance, types of ground truth, or training set details.
The letter primarily focuses on the regulatory clearance process and the device's classification. To obtain the information you're asking for, one would typically need to consult the original 510(k) submission document or a more detailed technical report on the device's testing.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized design featuring three human profiles facing to the right, with flowing lines suggesting movement or progress.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 1 1 1998
Mr. Scott Ryan Bill Olson Corp. 5350 Southwest First Lane Ocala, FL 34474
Re : K973238 Zefon Anesthesia Circuit with Bacterial Filter Requlatory Class: II (two) Product Code: 73 CAH Dated: February 20, 1998 February 24, 1998 Received:
Dear Mr. Ryan:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 A substantially equivalent determination assumes compliance to 895. with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) ---------inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{1}------------------------------------------------
Page 2 - Mr. Scott Ryan
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Thomas J. Callahon
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
510(k) Number (if known): K973238
Device Name: Zefon Anesthesia Circuit with Bacterial Filter
Indications For Use:
The Zefon Anesthesia Circuit with Bacterial Filter is intended for use in the administration of medical gases during anesthesia. The circuit connects the anesthesia gas machine to the patient by means of an oronasal face mask or by a connection to an artificial airway, such as an endotracheal tube. In the case of the Zefon circuit, a heat moisture exchange filter is included to minimize viral and bacterial contamination of the inspiratory and expiratory limbs of the circuit.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
M. Ruy
(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices 1973238 510(k) Number
Prescription Use
(Per 21 CFR 801.109)
OR :
Over-The-Counter Use
(Optional Format 1-2-96)
Exhibit 13
§ 868.5260 Breathing circuit bacterial filter.
(a)
Identification. A breathing circuit bacterial filter is a device that is intended to remove microbiological and particulate matter from the gases in the breathing circuit.(b)
Classification. Class II (performance standards).